News
Novo Nordisk underestimated the impact of competition from personalized compounded drugs when providing sales estimates for ...
Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.
For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat ...
Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed by: TOM MURPHY, Associated Press Posted: Jul 7, 2025 / 07:08 AM PDT Updated: Jul 7, 2025 / 07:08 AM PDT ...
Twenty years ago, Roger Cone, Ph.D. made a key discovery in obesity science which could help Courage Therapeutics deliver ...
Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy ...
Key Takeaways Patients and doctors are disagreeing about sleep apnea treatment Doctors favor the use of CPAP machines But patients with obesity would rather use Zepbound to ease their apnea MONDAY ...
4h
InvestorsHub on MSNHims and Hers shares drop after revenue falls short amid GLP-1 scrutiny
Shares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of ...
I have been diagnosed with mild sleep apnea. (No surprise there as symptoms were omnipresent.) CPAP machines seem incredibly uncomfortable. Are they the preferred gold standard even for mild sleep ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results